The complex integration of carcinogenic mechanisms in NAFLD such as chronic inflammation, lipotoxicity, and high insulin levels can lead to a higher HCC risk, especially among patients with underlying T2DM. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.